Pick a Topic:
Find info on a:
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.
ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.
|
Jack E. Ansell, M.D.
Jack E. Ansell, MD, is the Michael S. Bruno, M.D. Chairman of the Department of Medicine at Lenox Hill Hospital. Dr. Ansell received his medical degree from the University Of Virginia School Of Medicine and completed his medical residency at Tufts New England Medical Center in Boston, Massachusetts. Dr. Ansell then completed a fellowship in Hematology at Boston University and in Hematology/Hemostasis at Boston’s Veterans Administration Hospital.
Dr. Ansell is an internationally recognized expert in the field of Hemostasis and Thrombosis. He has well over 200 publications including original research, reviews, editorials chapters, and books. He serves as an associate editor for the Journal of Thrombosis and Thrombolysis and Current Clinical Pharmacology and as an editorial consultant for such journals as The New England Journal of Medicine, Blood, Journal of Thrombosis and Haemostasis, and Circulation.
Dr. Ansell’s main areas of research focus on the clinical problems of thrombosis, thrombotic disorders, and antithrombotic therapy. He has had a continued involvement in the application of new modes of delivering and monitoring anticoagulants, particularly in the management of oral anticoagulant therapy and has been increasingly involved in the clinical study of new oral anticoagulants.
Dr. Ansell is the founder and immediate past Chair of the Anticoagulation Forum, a network of anticoagulation clinics throughout North America, and he is currently Chair of the Medical and Scientific Advisory Board of the National Alliance for Thrombosis and Thrombophilia, a patient advocacy group. He is a member of a number of professional organizations including the American College of Physicians (Fellow), the American Society of Hematology, the International Society of Thrombosis and Hemostasis, the American Heart Association (Fellow), and the American Medical Association. Dr. Ansell also serves as the Chair of two consensus committees of the American College of Chest Physicians involved in establishing national guidelines on antithrombotic therapy. These include the topics of: Managing Oral Anticoagulation and The Perioperative Management of Antithrombotic Therapy.
Editorial Board Members
-
Henry I. Bussey, Pharm.D., FCCP -- San Antonio, TX
-
Marie Bussey, BBA, BS -- San Antonio, TX
-
Mary Amato, Pharm.D., MPH -- Boston, MA
-
Jack E. Ansell, M.D. -- New York, NY
-
William E. Dager, Pharm.D., FCSHP -- Sacramento, CA
-
Susan C. Fagan, Pharm.D., BCPS, FCCP -- Augusta, GA
-
Samuel Z. Goldhaber, M.D. -- Boston, MA
-
James B. Groce III, Pharm.D., CACP -- Greensboro, NC
-
Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA -- W. Palm Beach, FL
-
David W. Hawkins, Pharm.D. -- Sacramento, CA
-
Elaine M. Hylek, MD, MPH -- Boston, MA
-
Roger M. Lyons, MD, FACP -- San Antonio, TX
-
Edith A. Nutescu, Pharm.D. -- Chicago, IL
-
Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) -- Philadelphia, PA
-
Alex C. Spyropoulos, MD, FACP, FCCP -- Rochester, NY
-
Victor F. Tapson, M.D. -- Durham, NC
-
Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC -- Hamilton, Ontario, Canada
-
Robert T. Weibert, Pharm.D. -- San Diego, CA
-
Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP -- Seattle, WA
Return to Editorial Board main page
|
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
New Postings:
Click here to view full list of new postings
|